key: cord-0918214-ulhpr4i5
authors: Yates, Thomas; Zaccardi, Francesco; Islam, Nazrul; Razieh, Cameron; Gillies, Clare L.; Lawson, Claire A.; Chudasama, Yogini; Rowlands, Alex; Davies, Melanie J.; Docherty, Annemarie B.; Openshaw, Peter J. M.; Baillie, J. Kenneth; Semple, Malcolm G.; Khunti, Kamlesh
title: Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID‐19: Analysis of the ISARIC CCP‐UK Cohort
date: 2021-05-14
journal: Obesity (Silver Spring)
DOI: 10.1002/oby.23178
sha: af5bbec8c2a97b8733bc935b9937f983a4c9470f
doc_id: 918214
cord_uid: ulhpr4i5

OBJECTIVE: The aim of this study was to investigate the association of obesity with in‐hospital coronavirus disease 2019 (COVID‐19) outcomes in different ethnic groups. METHODS: Patients admitted to hospital with COVID‐19 in the United Kingdom through the Clinical Characterisation Protocol UK (CCP‐UK) developed by the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) were included from February 6 to October 12, 2020. Ethnicity was classified as White, South Asian, Black, and other minority ethnic groups. Outcomes were admission to critical care, mechanical ventilation, and in‐hospital mortality, adjusted for age, sex, and chronic diseases. RESULTS: Of the participants included, 54,254 (age = 76 years; 45.0% women) were White, 3,728 (57 years; 41.1% women) were South Asian, 2,523 (58 years; 44.9% women) were Black, and 5,427 (61 years; 40.8% women) were other ethnicities. Obesity was associated with all outcomes in all ethnic groups, with associations strongest for black ethnicities. When stratified by ethnicity and obesity status, the odds ratios for admission to critical care, mechanical ventilation, and mortality in black ethnicities with obesity were 3.91 (3.13‐4.88), 5.03 (3.94‐6.63), and 1.93 (1.49‐2.51), respectively, compared with White ethnicities without obesity. CONCLUSIONS: Obesity was associated with an elevated risk of in‐hospital COVID‐19 outcomes in all ethnic groups, with associations strongest in Black ethnicities.

► People of South Asian or Black ethnic origin have been shown to have a higher risk of infection, severe disease, and coronavirus disease 2019 (COVID- 19) mortality compared with those of White ethnicities. ► Obesity is an established risk factor for COVID- 19 outcomes, but less is known about whether ethnicity acts to modify the strength of association observed with obesity or whether the risk remains consistent across ethnic groups.

What does this study add?

► Compared with White individuals without obesity, all other combinations of obesity and ethnicity had a higher risk of admission to critical care, receiving mechanical ventilation, or mortality in those admitted to hospital with COVID-19. However, the risk of all outcomes was greatest in those of Black ethnicity with obesity.

How might these results change the direction of research or the focus of clinical practice?

► Black ethnic groups with obesity represent a particularly high-risk group of patients, with implications for targeted public health and vaccination strategies and for identifying those most likely to suffer severe outcomes once admitted to hospital.

Obesity and ethnicity are well-described risk factors for coronavirus disease 2019 (COVID- 19) outcomes (1) (2) (3) (4) (5) (6) (7) . People of South Asian or Black ethnic origin, in particular, have been shown to carry a higher risk of infection, severe disease, and COVID-19 mortality compared with those of White ethnicities (1) (2) (3) (4) (5) . In addition, individuals with obesity have around twice the risk of severe outcomes or mortality compared with normal-weight individuals (6, 7) . However, although obesity and ethnicity were shown to be independent of each other as risk factors for COVID-19 outcomes, less is known about whether ethnicity acts to modify the strength of association observed with obesity or whether the risk remains consistent across different ethnic groups.

The hypothesis that ethnicity may modify associations between obesity and COVID-19 outcomes is drawn from previous research, suggesting that the dose-repose relationship between levels of obesity and cardiometabolic health is steeper in minority ethnic communities compared with White populations: indeed, the higher the BMI, the greater the difference in health outcomes between minority ethnic groups and White Europeans (8) (9) (10) (11) (12) . As cardiometabolic diseases are known risk factors for COVID-19 outcomes (13) (14) (15) (16) , it is possible that obesity may also act as a particularly important risk factor for severe COVID-19 outcomes in minority ethnic communities. Early research supports this hypothesis, in which the risk of severe acute respiratory syndrome coronavirus 2 infection, severe disease, and COVID-19 mortality in minority ethnic communities has been shown to be magnified in the presence of obesity (17, 18) , although this has not been confirmed in all studies (19) . However, evidence to date is preliminary and based on small cohorts with a limited number of outcomes, with minority ethnic groups analyzed as one category. As minority ethnic groups cover heterogeneous populations, it remains uncertain whether associations between obesity and COVID-19 outcomes differ in all minority ethnic groups or how they apply to national in-hospital settings.

Investigating whether obesity is a stronger risk factor for in-patient outcomes in specific minority ethnic groups will help inform public health and vaccination strategies aimed at identifying and targeting patients at greatest risk along with informing in-hospital clinical decisionmaking. In this view, we investigated associations of obesity and ethnicity with in-hospital critical care and mortality outcomes in patients admitted with COVID-19 using data from the Clinical Characterisation Protocol UK (CCP-UK), a preparedness protocol for severe emerging diseases developed by the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) cohort (20 We hypothesized that obesity will be a stronger risk factor for inhospital outcomes within some minority ethnic groups.

The protocol, amendment history, case report form, information leaflets, consent forms, and details of the Independent Data and Material Covariates. Age was measured to the nearest year based on the difference between date of birth and hospital admission date. Sex was coded as male or female. Chronic disease was based on cliniciandiagnosed status. In this study, we included diseases that have been consistently associated with COVID-19 outcomes (13-16): chronic cardiac disease (coronary artery disease, heart failure, congenital heart disease, cardiomyopathy, rheumatic heart disease), chronic kidney disease (diagnosed chronic kidney disease or estimated glomerular filtration rate <60 mL/min/1.73 m 2 ), chronic pulmonary disease (chronic obstructive pulmonary disease [chronic bronchitis, emphysema], cystic fibrosis, bronchiectasis, interstitial lung disease, preexisting requirement for long-term oxygen therapy), diabetes (type 1 or 2), and malignant neoplasm (current solid organ or hematological malignancy).

In-hospital treatment for COVID-19 was coded at discharge or death. The two main treatment types of oral or intravenous corticosteroids (including dexamethasone) and antivirals were included in this analysis.

Outcome. The main outcomes were admission to a critical care facility (intensive care unit [level 3] or high-dependency unit [level 2]), any deployed usage of a mechanical ventilation procedure (tracheal intubation or tracheostomy), and in-hospital mortality.

We use logistic regression to quantify associations between obesity and outcomes stratified by ethnicity: odds ratios (ORs) were adjusted for age, sex, and the presence of comorbidities (diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer). Stratified analysis was undertaken to assess whether the pattern of association of obesity with assessed outcomes in each ethnic group was consistent across strata of age (<70 years, ≥70 years), sex and presence of any chronic disease (defined as diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer).

To further assess the pattern of associations for both obesity and ethnicity, we defined mutually exclusive groups of ethnicity and obesity and estimated ORs in each category compared with White individuals without obesity (reference group). Sensitivity analysis was undertaken to assess whether the association between mutually exclusive groups of ethnicity and obesity with mortality were independent of in-hospital corticosteroid and antiviral treatments.

In order to account for missing obesity and covariate data, all analysis was conducted using multiple imputation through the Markov chain Monte Carlo imputation algorithm across five iterations. Associations with obesity within each ethnicity were also derived using a complete case data set as a sensitivity analysis.

All analyses were conducted in SPSS version 26 (IBM Corp., Armonk, New York). Data are reported with 95% CI unless reported otherwise; P < 0.05 was considered significant (e.g., in which the 95% CI does not cross the null).

Of Table 3 ). The pattern of association of obesity within each ethnic group was the same when the analysis was restricted to a complete case data set (Supporting Information  Table S1 ). Associations within each ethnic group were also similar in men and women ( Figure 1 ) but tended to be weaker in those with chronic disease or older (≥70 years) adults, particularly for mortality (Figure 1 ), in which no associations were seen in older adults for any ethnicity. The strongest association for obesity with mortality within assessed strata was observed in Black ethnicities without coexisting chronic disease (OR = 2.95; 95% CI: 1.84-4.74) (Figure 1 ). Figure 2 shows the association of mutually exclusive categories of obesity and ethnicity with outcomes. Figure 2 ). When considering patients with obesity, the risk of mortality was elevated in all ethnic groups; those with Black ethnicity and obesity had the greatest risk (1.93; 95% CI: 1.49-2.51) (Figure 2 ). The pattern and strength of association of ethnicity and obesity with mortality was not affected by further adjusting for in-hospital corticosteroid and antiviral treatments (Supporting Information Figure S1 ).

In this large national study of patients hospitalized with COVID-19, obesity was associated with an increased risk of admission to critical care, receiving mechanical ventilation, and in-hospital mortality in all ethnic groups, with associations strongest in those under 70 years of age or without other chronic diseases. However, the risk was consistently strongest in Black ethnicities with obesity when compared with all other ethnic and obesity groupings, with a four to five times greater risk of admission to critical care or receiving mechanical ventilation and around twice the risk of in-hospital mortality compared with White ethnicities without obesity. The association of obesity with in-hospital outcomes was stronger than that of ethnicity; in individuals without obesity, ethnicity was only marginally associated with in-hospital mortality.

This study extends early preliminary findings from two different early analyses from the UK Biobank community cohort involving 1,087 positive cases and 189 deaths, in which obesity was a stronger predictor of positivity and COVID-19 mortality in non-White ethnicities (17, 18) . The present study suggests that in patients admitted to hospital, a clinical coding of obesity is a stronger risk factor in Black ethnic groups specifically rather than for minority ethnic groups in general. Obesity in South Asian and Other ethnic minority groups carried a similar level of risk as it did Obesity | VOLUME 29 | NUMBER 7 | JULY 2021 www.obesityjournal.org

Obesity, Ethnicity, and COVID-19 Yates et al. for White ethnicities. There are several hypothesized mechanisms that may explain these findings. Obesity has been hypothesized to increase the risk of severe COVID-19 through mechanisms linked to restricted pulmonary function and chronic inflammation (2, (22) (23) (24) ; adipose tissue has also been suggested as a viral reservoir (23) . Patients from Black ethnicities may have greater inflammatory responses to infection (24) (25) (26) , and excessive systemic innate inflammation due to obesity ("adipositis") is associated with susceptibility to other infectious diseases (27) . Because both clinical and genetic evidence strongly suggests that inflammatory processes drive mortality in COVID-19 (28, 29) , these mechanisms may place Black ethnicities with obesity at a higher risk of organ failure and death. It is also possible that sociodemographic factors, such as greater levels of deprivation and discrimination, may also act through a host of different mechanisms to lower resilience to infection or delay admission to hospital (24) , which again could become more severe in the presence of obesity. However, further research is required to disentangle the mechanisms behind the observations reported in this paper.

Associations with obesity in each ethnic group were consistent across men and women but tended to be weaker in older (≥70 years) adults or those with coexisting chronic disease, particularly for the outcome of mortality, in which no association between obesity and mortality was seen in any ethnic group in older adults. Although there was a high level of uncertainty in older minority ethnic populations due to a younger average age and the resulting limited sample of older adults, the findings are consistent with another in-hospital study in which associations of BMI with mortality or mechanical ventilation were largely attenuated in those over 70 years of age (30) . Therefore, the findings from this study may only be generalizable to those under 70 years of age, with ethnic specific associations in older adults needing further investigation. Obesity may also be a particularly strong risk factor for severe COVID-19 outcomes in otherwise healthy adults, where the highest odds of COVID-19 mortality with obesity was seen in Black ethnicities without other coexisting chronic diseases.

Strengths of this analysis include the large multisite national sample with data captured from clinical records by trained individuals using standardized operating procedures, allowing the largest analysis of COVID-19 outcomes with obesity and ethnicity to date. However, there are some important limitations. Obesity was defined through clinician assessment, with the prevalence an underestimate compared with levels that would have been expected based on population estimates (31). Thus, the coding of obesity possibly reflects more extreme phenotypes of obesity that are likely to prompt a clinical coding, and it is unknown whether this procedure was biased by ethnicity. However, the pattern of obesity prevalence in this sample is broadly consistent with national survey data for overweight and obesity prevalence (32), with rates higher in Black ethnic groups but lower in other minority ethnic groups compared with White ethnicities. It is also important to note that, in order to inform clinical care, analyzed risk factors need to reflect data that are readily available to treating clinical staff through clinical records. Therefore, the coding of obesity in this study may have real-world utility as it corresponds to data collected within routine clinical care. Another potential Figure 1 Associations of obesity (compared with those without obesity) with critical care, mechanical ventilation, and mortality for each ethnicity stratified by age, sex, and chronic disease. Error bars display 95% CI. Sex strata adjusted for age, diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer. Age strata adjusted for sex, diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer. Chronic disease strata adjusted for age and sex. [Color figure can be viewed at wileyonlinelibrary.com] Figure 2 Risk of admittance to critical care, mechanical ventilation, and mortality across categories of obesity and ethnicity compared with White individuals without obesity. Error bars display 95% CI. Adjusted for age, sex, diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer. [Color figure can be viewed at wileyonlinelibrary.com] Obesity www.obesityjournal.org Obesity | VOLUME 29 | NUMBER 7 | JULY 2021 1229

Original Article EPIDEMIOLOGY/GENETICS limitation is that the coding of ethnicity was designed to be consistent with international definitions, rather than those designed for the UK populations. As such, it is acknowledged that the terms "Black," "South Asian," "White," and "other" cover a wide range of different cultures and races. Consequently, our analyses may have masked important differences between further stratified ethnic groups. However, comparisons using these broad ethnic groupings are informative for understanding initial ethnic differences that can then be further and more granularly investigated. Finally, this analysis did not have access to potential sociodemographic confounders, such as deprivation, housing, or employment status. However, the purpose of this analysis was to highlight ethnic differences in the strength of obesity as a global risk factor for in-hospital outcomes following admission with COVID-19, rather than for supporting potential etiological conclusions around reducing levels of obesity per se.

In conclusion, although obesity was a consistent risk factor for adverse in-hospital outcomes following admission with COVID-19 within all ethnic groups, particularly for younger adults without coexisting chronic disease, the risk with obesity was greatest in Black ethnicities compared with other ethnic groups. Black ethnic groups with obesity therefore represent a particularly high-risk group of patients with implications for targeted public health and vaccination strategies and for identifying those most likely to suffer severe outcomes once admitted to hospital.O

ISARIC Coronavirus Clinical Characterisation Consortium (ISARIC4C) Investigators: consortium lead investigator

Carrol Gamble; data integration and presentation

Shico Visuvanathan

Factors associated with COVID-19-related death using OpenSAFELY

Office for National Statistics (ONS). Coronavirus (COVID-19) related deaths by ethnic group

Updating ethnic contrasts in deaths involving the coronavirus (COVID-19)

The impact of ethnicity on clinical outcomes in COVID-19: a systematic review

Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis

The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis

Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis

Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study

Deriving ethnic-specific BMI cutoff points for assessing diabetes risk

Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK biobank participants

Ethnicityspecific obesity cut-points in the development of type 2 diabetes-a prospective study including three ethnic groups in the United Kingdom

Defining obesity cut-off points for migrant South Asians

Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis

The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank

Body mass index and risk of COVID-19 across ethnic groups: analysis of UK Biobank

Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization

Open source clinical science for emerging infections

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

SARS-CoV-2 infection and obesity: common inflammatory and metabolic aspects

The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections

COVID-19 and ethnicity: a novel pathophysiological role for inflammation

Genetic ancestry and natural selection drive population differences in immune responses to pathogens

Protective innate immune variants in racial/ethnic disparities of breast and prostate cancer

Host susceptibility to severe influenza A virus infection

Remdesivir for the treatment of Covid-19-final report

Genetic mechanisms of critical illness in Covid-19

Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Disease Registry

Overweight adults: by ethnicity over time

The ISARIC WHO CCP-UK study was registered at https://www.isrctn.com/ISRCT N6672 6260 and designated an Urgent Public Health Research Study by NIHR.The study protocol is available at https://isari c4c.net/proto cols. This work uses data provided by patients and collected by the National Health Service (NHS) as part of their care and support campaign #DataSavesLives. We are grateful to the 2,648 frontline NHS clinical and research staff and volunteer medical students who collected the data in challenging circumstances and the generosity of the participants and their families for their individual contributions in these difficult times. We also acknowledge the support of Jeremy J. Farrar and Nahoko Shindo. Supporting information: Additional Supporting Information may be found in the online version of this article.